Evidence map›Paper›PMID 41514618›Full record

ArticleCancers2025

Serum Levels of Soluble Forms of Fas and FasL in Patients with Pancreatic and Papilla of Vater Adenocarcinomas.

Stavros Anagnostoulis, Helen Bolanaki, Byron Asimakopoulos, Dimitrios Ouroumidis, Maria Koutini, Spyridon Patris, Ioannis Tzimagiorgis, Anastasios J Karayiannakis

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Stavros AnagnostoulisSecond Department of Surgery, Medical School, Democritus University of Thrace, 68100 Alexandroupolis, Greece.
Helen BolanakiSecond Department of Surgery, Medical School, Democritus University of Thrace, 68100 Alexandroupolis, Greece.ORCID 0009-0004-2763-9557
Byron AsimakopoulosLaboratory of Physiology, Medical School, Democritus University of Thrace, 68100 Alexandroupolis, Greece.
Dimitrios OuroumidisSecond Department of Surgery, Medical School, Democritus University of Thrace, 68100 Alexandroupolis, Greece.ORCID 0009-0004-5869-0806
Maria KoutiniSecond Department of Surgery, Medical School, Democritus University of Thrace, 68100 Alexandroupolis, Greece.ORCID 0000-0003-1976-3780
Spyridon PatrisSecond Department of Surgery, Medical School, Democritus University of Thrace, 68100 Alexandroupolis, Greece.ORCID 0009-0006-8773-8615
Ioannis TzimagiorgisSecond Department of Surgery, Medical School, Democritus University of Thrace, 68100 Alexandroupolis, Greece.ORCID 0009-0001-8855-6358
Anastasios J KarayiannakisSecond Department of Surgery, Medical School, Democritus University of Thrace, 68100 Alexandroupolis, Greece.ORCID 0000-0002-9278-4273

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

pancreatic carcinomaprognosissFassFasLsurgerysurvivalVater carcinoma

Identifiers

PMID41514618
PMCPMC12784731

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.